approval
saveORILISSA (ELAGOLIX SODIUM) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalDec 17, 2025 · 288d ago
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalJun 5, 2023 · 1214d ago
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalFeb 1, 2021 · 2068d ago
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalFeb 1, 2021 · 2068d ago
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalFeb 1, 2021 · 2068d ago
- approvalORILISSA (ELAGOLIX SODIUM) — FDA approvalJul 23, 2018 · 2992d ago
same company · ±60 days · 6
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalAug 16, 2019
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalJul 25, 2019
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalJul 25, 2019
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalJul 25, 2019
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJul 15, 2019
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJul 15, 2019
🐶 often sniffed alongside
top 7- tagApproval38 co-mentions · 12 sources
- drugORILISSA33 co-mentions · 12 sources
- tagSmall Molecule19 co-mentions · 12 sources
- drugORIAHNN (COPACKAGED)10 co-mentions · 5 sources
- drugelagolix sodium + estradiol + norethindrone + elagolix sodium5 co-mentions · 5 sources
- drugESTRING5 co-mentions · 5 sources
- drugnorethindrone5 co-mentions · 5 sources
comments(0)
5-min edit window · permanent after that